[Chronically inflamed intestinal diseases].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D002351:Carrageenan / Q000009:adverse effects; D002981:Clindamycin / Q000009:adverse effects; D003093:Colitis, Ulcerative / Q000473:pathology; D003106:Colon / Q000473:pathology; D003110:Colonic Neoplasms / Q000209:etiology; D003176:Complement C3 / Q000032:analysis; D003424:Crohn Disease / Q000473:pathology; D003602:Cytotoxicity, Immunologic; D003937:Diagnosis, Differential; D006801:Humans; D007082:Ileum / Q000473:pathology; D007412:Intestinal Fistula / Q000209:etiology; D007413:Intestinal Mucosa / Q000276:immunology / Q000473:pathology; D007414:Intestinal Neoplasms / Q000209:etiology; D007417:Intestinal Polyps / Q000209:etiology; D008034:Lincomycin / Q000009:adverse effects; D008532:Megacolon, Toxic / Q000209:etiology; D010288:Parenteral Nutrition; D011379:Prognosis; D011414:Properdin / Q000032:analysis; D013167:Spondylitis, Ankylosing / Q000235:genetics; D005719:gamma-Globulins / Q000032:analysis
D000900:Anti-Bacterial Agents; D001323:Autoantibodies; D003176:Complement C3; D005719:gamma-Globulins; D011414:Properdin; D002981:Clindamycin; D002351:Carrageenan; D008034:Lincomycin
Die chronisch entzündlichen Darmkrankheiten.